Defining access without excess: expanding appropriate use of antibiotics targeting multidrug-resistant organisms

Twisha S Patel(Centers for Disease Control and Prevention), Benjamin J. Park(University of Alabama at Birmingham), Fernanda C. Lessa(Centers for Disease Control and Prevention), Deborah Tong, Payal Patel(Intermountain Healthcare), Hatim Sati(World Health Organization), Solange C. Alves Carvalho, Melinda M. Neuhauser(Centers for Disease Control and Prevention), Arjun Srinivasan(Joint Commission), Lauri A. Hicks(Centers for Disease Control and Prevention), Haileyesus Getahun(World Health Organization - Pakistan), Maarten van der Heijden
The Lancet Microbe
October 11, 2023
10.1016/s2666-5247(23)00256-2
Cited by 20

Related Papers

Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)
|Clinical Infectious Diseases|2010|1.5k
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
|The Lancet Infectious Diseases|2025|526
Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis
|PLoS Medicine|2012|413
Surveillance for waterborne disease and outbreaks associated with recreational water use and other aquatic facility-associated health events--United States, 2005-2006.
|PubMed|2008|294
The <i>WHO AWaRe (Access, Watch, Reserve) antibiotic book</i> and prevention of antimicrobial resistance
|Bulletin of the World Health Organization|2023|276